Duvelisib Approved for Certain Lymphomas Duvelisib Approved for Certain Lymphomas
The FDA approved the new drug for use in relapsed or refractory chronic lymphocytic leukemia, small lymphocytic lymphoma, and follicular lymphoma.FDA Approvals
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news
More News: Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Health | Hematology | Leukemia | Lymphoma